Business · 15/05/2023Updated: 10/17/2026 · 1 min read
FDA Announces Final Decision on Withdrawal of MAKENA and Eight Abbreviated New Drug Applications
Summary
The FDA has made a final decision to withdraw approval of MAKENA and eight abbreviated new drug applications following a public hearing in October 2022, as announced by the Commissioner of Food and Drugs and the Chief Scientist.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →